We have recognized the benefit of partnering with the world’s leading research organisations since our inception. Research at the Institute has been greatly benefited by this, as well as its international reputation.
The Institute has formed strategic partnerships with organisations for their unique contributions. Among them are:
Australian Centre for Commercialization of Regenerative Medicine (CCRM Australia)
This not for profit organisation was formed in Australia in order to address bottlenecks in regenerative medicine translation and commercialization. CCRM Australia has been formed through the creation of the most extensive national regenerative medicine industry-led consortium by Australia’s leading researchers, industry, service providers and advocates. Its creation has been facilitated by Armi. Australia’s CCRM is modelled after Canada’s highly successful program. CCRM Australia is a member of the Global CCRM network and a partner to the industry’s leading consortium.
The Institute gains increased visibility through CCRM Australia’s global network of world-class companies. Besides providing business skills, leadership and potential funds for product development, it also provides receptor capacity for technology and products.
Hong Kong University of Science and Technology (CUHK)
CUHK and Monash University have established an integrated transnational partnership to create and invest in areas of shared excellence in medical education and research.Research programs and medical education platforms are expected to be developed as a result of synergistic collaborations.
By establishing this alliance between the medical faculties of each university, the Alliance aims to establish collaborative research enterprise that will have a long-term, significant effect. ARMI is a key part of the Alliance’s PhD exchange program. Researchers at ARMI and CUHK Institute for Tissue Engineering and Regenerative Medicine co-supervise selected ARMY PhD students.
EMBL Australia and EMBL Europe
ARMI through Monash University assumed responsibility for all EMBL-related activities in Australia when Australia became an Associate Member of the European Molecular Biology Laboratory (EMBL) in 2008. In Australia, ARMI has been instrumental in establishing the EMBL Australia Partner Laboratory, with nodes at the universities of Queensland and Melbourne, the EMBL Australia Bioinformatics Resource, the national EMBL Australia Training Programs, and other programs that are associated with EMBL.
Through research projects, infrastructure and training programs across Australia, EMBL Australia aims to maximise Australia’s associate membership of EMBL, by embedding powerful new enabling tools such as bioinformatics and systems biology into Australian life science. Monash University’s Biomedical Discovery Institute (BDI), which currently hosts EMBL Australia, maintains close collaboration with ARMI and Europe’s leading life sciences lab, EMBL.
We want to empower the global biomedical community in the shared quest to improve human health by discovering precise genomic solutions for diseases. It provides opportunities to exchange faculty, postgraduate students, and researchers; establish programs in teaching, research, and university administration; and identify other areas of mutual interest and cooperation. The Jackson Laboratory brings to the Institute expert knowledge in mouse biology, as well as training in mouse husbandry.
Students and faculty at the MDI Biological Laboratory and Monash University can participate in a new, international exchange program that will involve graduate students conducting PhD thesis research at Monash University, as well as medical students at Monash University.
As a result of this partnership, Maine and Australia might be able to establish business ties in biotech in areas of mutual interest.